6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2022

Commission File Number: 001-36515

 

 

Materialise NV

 

 

Technologielaan 15

3001 Leuven

Belgium

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 


EXHIBIT INDEX

 

Exhibit    Description
99.1    Press Release dated October 27, 2022


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

MATERIALISE NV
By:  

/s/ Wilfried Vancraen

Name:   Wilfried Vancraen
Title:   Chief Executive Officer

Date: October 27, 2022

EX-99.1

Exhibit 99.1

 

 

Materialise Reports Third Quarter 2022 Results

LEUVEN, Belgium—(BUSINESS WIRE)—October 27, 2022 — Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2022.

Highlights – Third Quarter 2022

 

   

Total revenue increased 11.7% to 58,288 kEUR compared to 52,195 kEUR for the third quarter of 2021.

 

   

Total deferred revenue from annual software sales and maintenance fees increased by 3,214 kEUR to 38,359 kEUR compared to December 31, 2021.

 

   

Adjusted EBITDA was 5,072 kEUR, compared to 9,739 kEUR for the 2021 period.

 

   

Net profit for the third quarter of 2022 was 1,413 kEUR, or 0.02 EUR per diluted share, compared to 8,657 kEUR, or 0.15 EUR per diluted share, for the 2021 period.

Executive Chairman Peter Leys commented, “Demand for the products and solutions of each of our three segments remained solid even in these uncertain macro-economic times. Materialise’s revenue increased by almost 12% compared to the same period last year and our deferred revenue from annual software sales and maintenance fees increased by almost 10% compared to December 31, 2021. As a result of our continued investment in our growth businesses, but also because of inflation and, in particular our increased labor costs, our Adjusted EBITDA for the quarter was 5,072 kEUR compared to 9,739 kEUR for the third quarter of 2021. Our results included operational investments in Identify3D, a developer of AM cloud security systems that we acquired on September 1, 2022.”

Third Quarter 2022 Results

Total revenue for the third quarter of 2022 increased 11.7% to 58,288 kEUR from 52,195 kEUR for the third quarter of 2021. Adjusted EBITDA amounted to 5,072 kEUR for the third quarter of 2022 compared to 9,739 kEUR for the 2021 period. The Adjusted EBITDA margin (Adjusted EBITDA divided by total revenue) for the third quarter of 2022 was 8.7%, compared to 18.7% for the third quarter of 2021.

Revenue from our Materialise Software segment increased 3.8% to 10,863 kEUR for the third quarter of 2022 from 10,468 kEUR for the same quarter last year. Segment EBITDA decreased, including the effect of ongoing investments in Link3D and Identify3D, to 202 kEUR from 3,708 kEUR while the segment EBITDA margin was 1.9% compared to 35.4% for the prior-year period.

Revenue from our Materialise Medical segment increased 13.1% to 21,391 kEUR for the third quarter of 2022 compared to 18,910 kEUR for the same period in 2021. Segment EBITDA amounted to 4,765 kEUR for the third quarter of 2022 compared to 5,251 kEUR while the segment EBITDA margin was 22.3% compared to 27.8% for the third quarter of 2021.

Revenue from our Materialise Manufacturing segment increased 14.1% to 26,033 kEUR for the third quarter of 2022 from 22,817 kEUR for the third quarter of 2021. Segment EBITDA amounted to 2,530 kEUR compared to 3,546 kEUR for the same period last year, while the segment EBITDA margin was 9.7% compared to 15.5% for the third quarter of 2021.

Gross profit was 32,042 kEUR compared to 31,076 kEUR for the same period last year, while gross profit as a percentage of revenue decreased to 55.0% compared to 59.5% for the third quarter of 2021.

Research and development (“R&D”), sales and marketing (“S&M”) and general and administrative (“G&A”) expenses increased, in the aggregate, 24.5% to 33,491 kEUR for the third quarter of 2022 from 26,900 kEUR for the third quarter of 2021.

Net other operating income increased to 1,166 kEUR from 355 kEUR for the third quarter of 2021.

Operating result amounted to (282) kEUR compared to 4,529 kEUR for the third quarter of 2021.

Net financial result was 2,173 kEUR compared to 4,203 kEUR for the third quarter of 2021.

The third quarter of 2022 contained income tax expenses of (478) kEUR, compared to (75) kEUR in the third quarter of 2021.

As a result of the above, net profit for the third quarter of 2022 was 1,413 kEUR, compared to 8,657 kEUR for the same period in 2021. Total comprehensive income for the third quarter of 2022, which includes exchange differences on translation of foreign operations, was 1,638 kEUR compared to 8,272 kEUR for the 2021 period.


At September 30, 2022, we had cash and cash equivalents of 150,621 kEUR compared to 196,028 kEUR at December 31, 2021. Gross debt amounted to 83,925 kEUR, compared to 99,107 kEUR at December 31, 2021. As a result, our net cash position (cash and cash equivalents less gross debt) was 66,696 kEUR, a decrease of 30,225 kEUR, and included the effect of our call option exercise to acquire 100% of the shares of Link3D, and of our acquisition of Identify3D.

Cash flow from operating activities for the third quarter of the year 2022 was 3,840 kEUR compared to 4,388 kEUR for the same period in 2021. Total capital expenditures for the third quarter of 2022 amounted to 9,441 kEUR.

Net shareholders’ equity at September 30, 2022 was 236,559 kEUR compared to 232,577 kEUR at December 31, 2021.

2022 Guidance

Mr. Leys concluded, “The revenue growth posted by each of our segments during the first nine months of this year strengthens our confidence that our full year 2022 revenues will be at least 10% higher than in 2021. While inflation and pressure on the labor market, which are higher and more persistent than we expected at the beginning of 2022, weigh on our results, we continue to make prudent investments in select growth businesses. As a result, we continue to expect that our consolidated EBITDA for the full year 2022 will be in the range of 20 mEUR to 25 mEUR.”

Non-IFRS Measures

Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of profit or loss in a joint venture and depreciation and amortization. Adjusted EBITDA is determined by adding share-based compensation expenses, acquisition-related expenses of business combinations, impairments and revaluation of fair value due to business combinations to EBITDA. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of long-term investment and financing decisions, rather than the performance of the company’s day-to-day operations. As compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company’s business, or the charges associated with impairments. Management evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company’s ability to grow or as a valuation measurement. The company’s calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company’s presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

Exchange Rate

This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 0.9748, the reference rate of the European Central Bank on September 30, 2022.

Conference Call and Webcast

Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the third quarter of 2022 on Thursday, October 27, 2022, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Wilfried Vancraen, Founder and Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session will follow management’s remarks.

 

   

To access the conference call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or to receive a call to connect to Materialise’s conference call.

 

   

https://register.vevent.com/register/BI66dc4a1f45c744f2ad3d85501fc27140

The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com. A webcast of the conference call will be archived on the company’s website for one year.


About Materialise

Materialise incorporates 30 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed conflict in Ukraine and the COVID-19 pandemic and related public health measures, as well as the related actions we are taking in response), and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company’s most recent actual results to differ materially from our expectations, including risk factors described in the company’s most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company’s actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.


Consolidated income statements (Unaudited)

 

     for the three months ended
September 30,
    for the nine months ended
September 30,
 
In ‘000    2022     2022     2021(*)     2022     2021(*)  
     U.S.$                  

Revenue

     56,819       58,288       52,195       169,319       148,461  

Cost of Sales

     (25,584     (26,245     (21,119     (76,236     (64,378

Gross Profit

     31,235       32,042       31,076       93,083       84,084  

Gross profit as % of revenue

     55.0     55.0     59.5     55.0     56.6

Research and development expenses

     (9,078     (9,313     (6,602     (26,074     (19,982

Sales and marketing expenses

     (14,815     (15,198     (12,413     (44,841     (35,730

General and administrative expenses

     (8,754     (8,980     (7,885     (26,089     (23,449

Net other operating income (expenses)

     1,137       1,166       355       2,603       2,318  

Operating (loss) profit

     (275     (282     4,529       (1,318     7,239  

Financial expenses

     (2,057     (2,110     2,334       (4,671     (3,182

Financial income

     4,175       4,283       1,869       9,800       4,426  

Share in loss of joint venture

     —         —         —         —         —    

(Loss) profit before taxes

     1,843       1,891       8,732       3,812       8,483  

Income Taxes (*)

     (466     (478     (75     (1,377     (101

Net (loss) profit for the period (*)

     1,377       1,413       8,657       2,435       8,382  

Net (loss) profit attributable to:

     —            

The owners of the parent

     1,385       1,421       8,660       2,457       8,386  

Non-controlling interest

     (8     (8     (3     (21     (4

Earning per share attributable to owners of the parent

 

       

Basic (*)

     0.02       0.02       0.15       0.04       0.15  

Diluted (*)

     0.02       0.02       0.15       0.04       0.15  

Weighted average basic shares outstanding

     59,064       59,064       58,731       59,064       55,935  

Weighted average diluted shares outstanding

     59,089       59,089       58,944       59,099       56,206  

 

(*)

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the nine months ended September 30 income taxes and net profit is (46)k€.

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the three months ended September 30 income taxes and net profit is 5 k€.


Consolidated statements of comprehensive income (Unaudited)

 

     for the three months ended
September 30,
    for the nine months ended
September 30,
 
In 000€    2022     2022     2021(*)     2022     2021(*)  
     U.S.$                  

Net profit (loss) for the period (*)

     1,377       1,413       8,657       2,435       8,382  

Other comprehensive income

          

Recycling

          

Exchange difference on translation of foreign operations

     219       225       (385     1,291       1,590  

Non-recycling

          

Fair value adjustments through OCI—Equity instruments

     —         —         —         (0     48  

Other comprehensive income (loss), net of taxes

     219       225       (385     1,291       1,638  

Total comprehensive income (loss) for the year, net of taxes

     1,596       1,638       8,272       3,726       10,020  

Total comprehensive income (loss) attributable to:

          

The owners of the parent

     1,604       1,646       8,275       3,748       10,023  

Non-controlling interests

     (8     (8     (3     (21     (3

 

(*)

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the nine months ended September 30 income taxes and net profit is (46)k€.

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the three months ended September 30 income taxes and net profit is 5 k€.


Consolidated statement of financial position (Unaudited)                

 

     As of
September 30,
     As of
December 31,
 
In 000€    2022      2021  

Assets

     

Non-current assets

     

Goodwill

     50,190        18,726  

Intangible assets

     38,710        31,668  

Property, plant & equipment

     92,335        84,451  

Right-of-Use assets

     8,520        9,054  

Investments in joint ventures

     —          —    

Deferred tax assets

     217        227  

Investments in convertible loans

     3,431        3,560  

Investments in non-listed equity instruments

     399        399  

Other non-current assets

     4,948        7,520  

Total non-current assets

     198,750        155,605  

Current assets

     

Inventories

     15,532        11,295  

Trade receivables

     42,329        41,541  

Other current assets

     8,374        8,940  

Cash and cash equivalents

     150,621        196,028  

Total current assets

     216,856        257,803  

Total assets

     415,606        413,408  


     As of
September 30,
    As of
December 31,
 
In 000€    2022     2021  

Equity and liabilities

    

Equity

    

Share capital

     4,487       4,489  

Share premium

     233,869       233,872  

Retained earnings and other reserves

     (1,797     (5,784

Equity attributable to the owners of the parent

     236,559       232,577  

Non-controlling interest

     (21     1  

Total equity

     236,538       232,578  

Non-current liabilities

    

Loans & borrowings

     58,126       72,637  

Lease liabilities

     5,004       5,268  

Deferred tax liabilities

     4,239       4,371  

Deferred income

     6,932       4,952  

Other non-current liabilities

     1,027       2,168  

Total non-current liabilities

     75,328       89,396  

Current liabilities

    

Loans & borrowings

     17,593       17,849  

Lease liabilities

     3,202       3,353  

Trade payables

     25,038       20,171  

Tax payables

     1,128       783  

Deferred income

     36,112       33,306  

Other current liabilities

     20,667       15,972  

Total current liabilities

     103,740       91,434  

Total equity and liabilities

     415,606       413,408  


Consolidated statement of cash flows (Unaudited)

 

     for the nine months ended
September 30,
 
In 000€    2022     2021*  

Operating activities

    

Net (loss) profit for the period (*)

     2,435       8,382  

Non-cash and operational adjustments

    

Depreciation of property plant & equipment

     11,335       11,460  

Amortization of intangible assets

     4,859       3,780  

Impairment of goodwill and intangible assets

     —         —    

Share-based payment expense

     (121     (878

Loss (gain) on disposal of property, plant & equipment

     59       43  

Movement in provisions

     (506     7  

Movement reserve for bad debt and slow moving inventory

     (42     154  

Financial income

     (9,771     (4,426

Financial expense

     5,009       3,182  

Impact of foreign currencies

     98       107  

Share in loss (gain) of a joint venture (equity method)

     —         —    

(Deferred) income taxes (*)

     1,384       101  

Other non-current liabilities

     —         —    

Working capital adjustments

     9,109       (4,531

Decrease (increase) in trade receivables and other receivables

     (184     (7,553

Decrease (increase) in inventories and contracts in progress

     (4,356     (1,770

Increase (decrease) in deferred revenue

     3,815       (56

Increase (decrease) in trade payables and other payables

     9,834       4,848  

Income tax paid & Interest received

     (262     108  

Net cash flow from operating activities

     23,587       17,490  

 

(*)

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on Net profit for the period and on (Deferred) income taxes is (46) k€.


     for the nine months ended
September 30,
 
In 000€    2022     2021  

Investing activities

    

Purchase of property, plant & equipment

     (16,066     (4,827

Purchase of intangible assets

     (3,422     (2,439

Proceeds from the sale of property, plant & equipment & intangible assets (net)

     319       295  

Acquisition of subsidiary (net of cash)

     (29,355     —    

(Convertible) Loans granted

     —         1,239  

Investment in subsidiary, net of cash acquired

     —         (1,680

Net cash flow used in investing activities

     (48,523     (7,412

Financing activities

    

Repayment of loans & borrowings

     (15,182     (11,169

Repayment of leases

     (2,566     (2,841

Capital increase

     —         85,787  

Interest paid

     (1,665     (1,652

Other financial income (expense)

     1,378       2,740  

Net cash flow from (used in) financing activities

     (18,035     72,865  

Net increase/(decrease) of cash & cash equivalents

     (42,972     82,943  

Cash & Cash equivalents at the beginning of the year

     196,028       111,538  

Exchange rate differences on cash & cash equivalents

     (2,433     465  

Cash & cash equivalents at end of the period

     150,621       194,946  


Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

 

     for the three months ended
September 30,
    for the nine months ended
September 30,
 
In 000€    2022     2021 (*)     2022     2021 (*)  

Net profit (loss) for the period (*)

     1,413       8,657       2,435       8,382  

Income taxes (*)

     478       75       1,377       101  

Financial expenses

     2,110       (2,334     4,671       3,182  

Financial income

     (4,283     (1,869     (9,800     (4,426

Depreciation and amortization

     5,378       5,314       16,194       15,240  

Share in loss of joint venture

     —         —         —         —    

EBITDA

     5,096       9,843       14,876       22,480  

Share-based compensation expense (1)

     (24     (104     (121     (878

Acquisition-related expenses of business combinations (2)

     —         —         —         405  

Adjusted EBITDA

     5,072       9,739       14,755       22,007  

 

(1)

Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.

(2)

Acquisition-related expenses of business combinations represents expenses incurred in connection with the acquisition of our option to buy Link3D.

(*)

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the nine months ended September 30 income taxes and net profit is (46)k€.

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the three months ended September 30 income taxes and net profit is 5 k€.


Segment P&L (Unaudited)

 

In 000€    Materialise
Software
    Materialise
Medical
    Materialise
Manufacturing
    Total
segments
    Unallocated
(1)
    Consolidated  

For the three months ended September 30, 2022

            

Revenues

     10,863       21,391       26,033       58,288       0       58,288  

Segment (adj) EBITDA

     202       4,765       2,530       7,497       (2,425     5,072  

Segment (adj) EBITDA %

     1.9     22.3     9.7     12.9       8.7

For the three months ended September 30, 2021

            

Revenues

     10,468       18,910       22,817       52,196       (0     52,195  

Segment (adj) EBITDA

     3,708       5,251       3,546       12,506       (2,767     9,739  

Segment (adj) EBITDA %

     35.4     27.8     15.5     24.0       18.7
In 000€    Materialise
Software
    Materialise
Medical
    Materialise
Manufacturing
    Total
segments
    Unallocated
(1)
    Consolidated  

For the nine months ended September 30, 2022

            

Revenues

     31,989       60,592       76,739       169,319       0       169,319  

Segment (adj) EBITDA

     2,955       12,466       6,722       22,144       (7,388     14,755  

Segment (adj) EBITDA %

     9.2     20.6     8.8     13.1       8.7

For the nine months ended September 30, 2021

            

Revenues

     30,719       52,686       65,199       148,604       (142     148,461  

Segment (adj) EBITDA

     10,266       14,313       5,252       29,831       (7,826     22,004  

Segment (adj) EBITDA %

     33.4     27.2     8.1     20.1       14.8

 

(1)

Unallocated segment adjusted EBITDA consists of corporate research and development and corporate other operating income (expense), and the added share-based compensation expenses, acquisition related expenses of business combinations, impairments and fair value of business combinations that are included in Adjusted EBITDA.


Reconciliation of Net Profit (Loss) to Segment adjusted EBITDA (Unaudited)

 

     for the three months ended
September 30,
    for the nine months ended
September 30,
 
In 000€    2022     2021 (*)     2022     2021 (*)  

Net profit (loss) for the period (*)

     1,413       8,657       2,435       8,382  

Income taxes (*)

     478       75       1,377       101  

Financial cost

     2,110       (2,334     4,671       3,182  

Financial income

     (4,283     (1,869     (9,800     (4,426

Share in loss of joint venture

     —         —         —         —    

Operating (loss) profit

     (282     4,529       (1,318     7,239  

Depreciation and amortization

     5,378       5,314       16,194       15,240  

Corporate research and development

     592       710       2,057       2,191  

Corporate headquarter costs

     2,491       2,463       7,103       6,907  

Other operating income (expense)

     (681     (511     (1,892     (1,745

Segment adjusted EBITDA

     7,497       12,506       22,144       29,831  

 

(*)

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the nine months ended September 30 income taxes and net profit is (46)k€.

The year 2021 has been restated to reflect the final accounting of the business combination with RS Print. Impact on the three months ended September 30 income taxes and net profit is 5 k€.